ELAINE HARMON: Open Payments
NPI 1619189891 · KENNER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 6 payments from 5 companies in 2025. Trend: 2023 $219 · 2024 $194 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 2 | $150 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Fresenius USA Marketing, Inc. | 1 | $15 |
Products named: Vafseo, JYNARQUE, Ozempic, FARXIGA, VELPHORO.
Industry payments across LA — which companies pay providers there.
